focus -WSS

focus

author：fashion 2025-09-03 03:31:56 - browse：65288

A person picking up medication at a drive through pharmacy window – biotech and pharma coverage from STAT — Adobe

On Tuesday morning, the Department of Health and Human Services unveiled its long-awaited list of the 10 medicines that will be subject to price negotiation in 2026 under the Inflation Reduction Act.

This will mark the first time that Medicare, the government program for paying for health care for older Americans, will have any ability to use its vast size to negotiate for lower prices. It’s not yet clear how big the discounts on these 10 drugs will be, or even if the law will hold up to multiple legal challenges from the pharmaceutical industry. It’s also not clear, as critics from the drug industry have noted, whether any savings to the government will be passed on to consumers.

Still, the naming of 10 medicines is a milestone, and a point to start appraising the impact of the law. The landscape here is complicated. No one really knows how the IRA’s price negotiation process will play out over the short and long term, and many companies who had products named were spared in other ways, with products many industry watchers expected to see on the list absent. Here is STAT’s assessment of who has won and lost.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

WSS

Dana Farber says 6 studies to be retracted and 31 corrected

High breast density mammograms need follow

Childhood vaccination ad campaign launches in the U.K.

Laying a path for careers in science

Are embryos people? Reproductive medicine's future depends on the answer

Cardiologists urge adding sexual orientation, gender identity to health records

focus

focus

leisure time

In age of alternative facts, a scholarly course on calling out crap

To bolster infectious disease surveillance, genomics powerhouses team up

Peter Hotez and the public health issue of online harassment

A pediatrician calls for Congress to pass the child tax credit deal

How to save PrEP access — and even expand it

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Medicare isn't yet testing food as medicine

entertainment

Immunocompromised patients offer clues on chronic Covid

Inaction leaves children at risk from dangerous chemotherapy drug

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

What causes osteoarthritis? Researchers study link to brain protein

Printout prescription drug information shouldn’t go digital

Printout prescription drug information shouldn’t go digital

knowledge

entertainment

Wikipedia

hotspot